A detailed history of Nicolet Advisory Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nicolet Advisory Services, LLC holds 641 shares of VRTX stock, worth $261,643. This represents 0.03% of its overall portfolio holdings.

Number of Shares
641
Previous 613 4.57%
Holding current value
$261,643
Previous $287,000 3.83%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $12,880 - $14,161
28 Added 4.57%
641 $298,000
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $26,318 - $32,530
67 Added 12.27%
613 $287,000
Q1 2024

May 09, 2024

SELL
$407.69 - $446.08 $20,792 - $22,750
-51 Reduced 8.54%
546 $228,000
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $8,575 - $10,267
25 Added 4.37%
597 $242,000
Q3 2023

Nov 07, 2023

BUY
$338.18 - $362.46 $193,438 - $207,327
572 New
572 $198,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nicolet Advisory Services, LLC Portfolio

Follow Nicolet Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Advisory Services, LLC with notifications on news.